Home > Income Statement > MANKIND PHARMA

MANKIND PHARMA
Income Statement

MANKIND PHARMA is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year Income Statement History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
INCOME :
Gross Sales ₹9,106 Cr₹8,071 Cr₹647 Cr₹61,007 Cr₹4,980 Cr
     Sales ₹9,048 Cr₹8,067 Cr₹646 Cr₹60,924 Cr₹4,969 Cr
     Job Work/ Contract Receipts ₹34 Cr----
     Processing Charges / Service Income ₹23 Cr₹3.46 Cr₹0.25 Cr₹16 Cr₹5.71 Cr
     Revenue from property development -----
     Other Operational Income ---₹68 Cr₹5.13 Cr
Less: Excise Duty -----
Net Sales ₹8,749 Cr₹7,782 Cr₹621 Cr₹58,719 Cr₹4,980 Cr
EXPENDITURE :
Increase/Decrease in Stock ₹291 Cr₹-450 Cr₹-25 Cr₹-105 Cr₹12 Cr
Raw Material Consumed ₹2,623 Cr₹2,871 Cr₹203 Cr₹18,885 Cr₹1,709 Cr
     Opening Raw Materials ₹399 Cr₹284 Cr₹25 Cr₹1,605 Cr₹127 Cr
     Purchases Raw Materials ₹1,829 Cr₹2,173 Cr₹141 Cr₹13,699 Cr₹982 Cr
     Closing Raw Materials ₹414 Cr₹399 Cr₹28 Cr₹2,331 Cr₹177 Cr
     Other Direct Purchases / Brought in cost ₹809 Cr₹814 Cr₹65 Cr₹5,912 Cr₹777 Cr
     Other raw material cost -----
Power & Fuel Cost ₹109 Cr₹103 Cr₹8.25 Cr₹800 Cr₹64 Cr
     Electricity & Power ₹109 Cr₹103 Cr₹8.25 Cr₹800 Cr₹64 Cr
     Oil, Fuel & Natural gas -----
     Coals etc -----
     Other power & fuel -----
Employee Cost ₹1,918 Cr₹1,621 Cr₹142 Cr₹13,355 Cr₹1,095 Cr
     Salaries, Wages & Bonus ₹1,788 Cr₹1,515 Cr₹133 Cr₹12,714 Cr₹1,037 Cr
     Contributions to EPF & Pension Funds ₹89 Cr₹74 Cr₹5.87 Cr₹429 Cr₹39 Cr
     Workmen and Staff Welfare Expenses ₹22 Cr₹15 Cr₹1.16 Cr₹89 Cr₹7.76 Cr
     Other Employees Cost ₹20 Cr₹17 Cr₹1.54 Cr₹123 Cr₹11 Cr
Other Manufacturing Expenses ₹151 Cr₹160 Cr₹14 Cr₹1,092 Cr₹85 Cr
     Sub-contracted / Out sourced services -----
     Processing Charges -----
     Repairs and Maintenance ₹39 Cr₹37 Cr₹2.70 Cr₹250 Cr₹16 Cr
     Packing Material Consumed -----
     Other Mfg Exp ₹112 Cr₹124 Cr₹11 Cr₹842 Cr₹69 Cr
General and Administration Expenses ₹1,001 Cr₹656 Cr₹45 Cr₹4,390 Cr₹508 Cr
     Rent , Rates & Taxes ₹132 Cr₹84 Cr₹5.86 Cr₹609 Cr₹60 Cr
     Insurance ₹15 Cr₹14 Cr₹1.04 Cr₹84 Cr₹7.12 Cr
     Printing and stationery ₹10 Cr₹7.02 Cr₹0.53 Cr₹43 Cr₹5.14 Cr
     Professional and legal fees ₹169 Cr₹88 Cr₹4.94 Cr₹308 Cr₹64 Cr
     Traveling and conveyance ₹496 Cr₹358 Cr₹27 Cr₹2,695 Cr₹297 Cr
     Other Administration ₹178 Cr₹105 Cr₹5.77 Cr₹651 Cr₹75 Cr
Selling and Distribution Expenses ₹638 Cr₹708 Cr₹59 Cr₹4,267 Cr₹522 Cr
     Advertisement & Sales Promotion ₹374 Cr₹452 Cr₹39 Cr₹2,553 Cr₹357 Cr
     Sales Commissions & Incentives ₹180 Cr₹174 Cr₹14 Cr₹1,244 Cr₹116 Cr
     Freight and Forwarding ₹84 Cr₹82 Cr₹6.15 Cr₹470 Cr₹49 Cr
     Handling and Clearing Charges -----
     Other Selling Expenses ₹0.28 Cr₹0.22 Cr₹0.02 Cr--
Miscellaneous Expenses ₹117 Cr₹121 Cr₹11 Cr₹1,587 Cr₹59 Cr
     Bad debts /advances written off ₹4.64 Cr₹4.92 Cr₹0.06 Cr₹6.12 Cr₹1.25 Cr
     Provision for doubtful debts ₹9.15 Cr₹9.65 Cr₹0.11 Cr₹59 Cr₹1.12 Cr
     Losson disposal of fixed assets(net) -₹3.74 Cr₹0.30 Cr-₹1.28 Cr
     Losson foreign exchange fluctuations ---₹10 Cr₹0.54 Cr
     Losson sale of non-trade current investments -----
     Other Miscellaneous Expenses ₹103 Cr₹103 Cr₹10 Cr₹1,511 Cr₹55 Cr
Less: Expenses Capitalised -----
Total Expenditure ₹6,848 Cr₹5,791 Cr₹457 Cr₹44,272 Cr₹4,055 Cr
Operating Profit (Excl OI) ₹1,902 Cr₹1,991 Cr₹165 Cr₹14,447 Cr₹925 Cr
Other Income ₹129 Cr₹196 Cr₹17 Cr₹1,038 Cr₹53 Cr
     Interest Received ₹13 Cr₹13 Cr₹3.83 Cr₹129 Cr₹5.61 Cr
     Dividend Received ₹0.00 Cr₹0.00 Cr₹0.04 Cr₹43 Cr₹0.31 Cr
     Profit on sale of Fixed Assets ₹1.67 Cr--₹19 Cr₹0.66 Cr
     Profits on sale of Investments ---₹351 Cr₹30 Cr
     Provision Written Back ₹4.15 Cr₹34 Cr₹0.77 Cr--
     Foreign Exchange Gains ₹10 Cr₹8.85 Cr₹0.05 Cr--
     Others ₹100 Cr₹140 Cr₹12 Cr₹496 Cr₹17 Cr
Operating Profit ₹2,030 Cr₹2,187 Cr₹182 Cr₹15,485 Cr₹978 Cr
Interest ₹46 Cr₹60 Cr₹2.12 Cr₹232 Cr₹44 Cr
     InterestonDebenture / Bonds -----
     Interest on Term Loan ₹36 Cr₹16 Cr₹1.55 Cr₹137 Cr₹39 Cr
     Intereston Fixed deposits -----
     Bank Charges etc ₹1.30 Cr₹4.02 Cr₹0.19 Cr₹17 Cr₹3.94 Cr
     Other Interest ₹8.42 Cr₹40 Cr₹0.38 Cr₹78 Cr₹1.18 Cr
PBDT ₹1,985 Cr₹2,127 Cr₹180 Cr₹15,253 Cr₹934 Cr
Depreciation ₹326 Cr₹167 Cr₹12 Cr₹991 Cr₹69 Cr
Profit Before Taxation & Exceptional Items ₹1,659 Cr₹1,960 Cr₹168 Cr₹14,262 Cr₹865 Cr
Exceptional Income / Expenses -----
Profit Before Tax ₹1,671 Cr₹1,975 Cr₹169 Cr₹14,377 Cr₹875 Cr
Provision for Tax ₹362 Cr₹522 Cr₹40 Cr₹3,816 Cr₹264 Cr
     Current Income Tax ₹332 Cr₹451 Cr₹39 Cr₹4,084 Cr₹269 Cr
     Deferred Tax ₹41 Cr₹49 Cr₹0.24 Cr₹-327 Cr₹-8.80 Cr
     Other taxes ₹-12 Cr₹21 Cr₹0.14 Cr₹59 Cr₹4.28 Cr
Profit After Tax ₹1,310 Cr₹1,453 Cr₹129 Cr₹10,561 Cr₹610 Cr
Extra items -----
Minority Interest ₹-28 Cr₹-19 Cr₹-2.76 Cr₹-257 Cr₹-32 Cr
Share of Associate -----
Other Consolidated Items -----
Consolidated Net Profit ₹1,282 Cr₹1,433 Cr₹127 Cr₹10,304 Cr₹579 Cr
Adjustments to PAT -----
Profit Balance B/F ₹6,735 Cr₹5,304 Cr₹407 Cr₹34,076 Cr₹2,860 Cr
Appropriations ₹8,017 Cr₹6,737 Cr₹533 Cr₹44,380 Cr₹3,439 Cr
     General Reserves -----
     Proposed Equity Dividend -----
     Corporate dividend tax -----
     Other Appropriation ₹4.85 Cr₹1.80 Cr₹2.74 Cr₹2,484 Cr₹31 Cr
Equity Dividend % ---₹310.00₹445.00
Earnings Per Share ₹32.00₹35.78₹31.59₹25.72₹14.44
Adjusted EPS ₹32.00₹35.78₹31.59₹25.72₹14.44

Compare Income Statement of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹102,240.6 Cr -2.1% -0.6% 33.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹431,352.0 Cr 1.7% -4.7% 48.8% Stock Analytics
DIVIS LABORATORIES ₹159,265.0 Cr 4.4% 3.1% 66% Stock Analytics
CIPLA ₹120,035.0 Cr -0.9% -1.7% 17.3% Stock Analytics
DR REDDYS LABORATORIES ₹101,286.0 Cr -1% -8.9% 6.5% Stock Analytics
ZYDUS LIFESCIENCES ₹95,461.4 Cr -1% -4% 48.4% Stock Analytics


MANKIND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

-2.1%

-0.6%

33.1%

SENSEX

-1.9%

-5%

17.5%


You may also like the below Video Courses